Bispecific Antibody targeting IL-1R1 and NLRP3 for Glaucoma

V. E. McGilligan (Inventor)

Research output: Patent

Original languageEnglish
Patent numberWO/2020/053446
Filing date2/09/19
Publication statusPublished - 19 Mar 2020

Cite this